MacroGenics Inc. (MGNX)

[MiamiGent]

MGNX I'm going with this
$10.50 +1.27 (+13.76%)
It's a bit of a bail, as I have other work to catch up on
Squeeze of 13% short, on a Citi upgrade to $13

Could turn into a several days hold, for incremental gains. Maybe 5% more today??

https://stockcharts.com/h-sc/ui?s=MGNX

Citigroup Upgrades Macrogenics to Buy, Raises Price Target to $13
BENZINGA 4:20 AM ET Dec-20-2023

Citigroup analyst Yigal Nochomovitz upgrades Macrogenics (MGNX.NaE) from Neutral to Buy and raises the price target from $7 to $13.


Company Profile
SectorHealth CareOpens in a new window
IndustryBiotechnologyOpens in a new window
Company LocationRockville, MD
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients with metastatic HER2-positive breast cancer who have received two or more prior anti-HER2 regimens. The company's pipeline of immuno-oncology product candidates includes MGC018, an antibody drug conjugate (ADC), which targets solid tumors expressing B7-H3; Enoblituzumab, a monoclonal antibody that targets B7-H3; and MGD024, an investigational bispecific CD123 x CD3 DART molecule to minimize cytokine-release syndrome for patients with hematologic malignancies. In addition, i